Aquinnah Pharmaceuticals Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Aquinnah Pharmaceuticals is a biotechnology research company based in Cambridge, Massachusetts, at 610 Main Street, with a team of 11 to 50 employees. The company focuses on research and development to modulate neurodegenerative stress granules believed to play a role in ALS, Alzheimer's disease, and other neurodegenerative conditions. Lead molecules are advancing to clinical studies designed to prevent and potentially reverse pathological stress granules in affected patients, with potential applicability to cognition impairment in Alzheimer's disease and other neurodegenerative diseases. Research activities include work on the relationship between stress granules and tau protein, including findings by co-founder Ben Wolozin, and efforts to identify small molecule drugs that modulate intracellular tau-stress granule biology. The company reports revenue in the range of $10 million to $25 million.

Get verified Aquinnah Pharmaceuticals emails free

Company overview Employee directory